Analysis of hospitalization expenses of 610 HIV/AIDS patients in Nantong, China
- PDF / 647,165 Bytes
- 8 Pages / 595.276 x 790.866 pts Page_size
- 75 Downloads / 118 Views
(2020) 20:813
RESEARCH ARTICLE
Open Access
Analysis of hospitalization expenses of 610 HIV/AIDS patients in Nantong, China Xun Zhuang1†, Yujia Chen1,2†, Zunyou Wu3, Sarah Robbins Scott3, Renfei Lu4, Zhengcheng Xu1, Yuhui Yu1, Wei Wang1, Luyao Cao1, Yuanyuan Liang1, Gang Qin4* and Meiyin Zou4*
Abstract Background: The goal of this study was to describe the expenses related to human immunodeficiency virus (HIV) and acquired immune deficiency syndrome (AIDS) management and care in Nantong Infectious Disease Hospital from October 2013 through June 2017. Methods: The information of 610 HIV/AIDS inpatients were collected from the Electronic Medical Record System of the hospital. Univariate and path analysis were employed to evaluate the association between hospitalization expense and its related factors. Results: The average hospitalization expenses per person was 5454 RMB (Renminbi, the currency of China, about $808 USD) and 23,555 RMB (about $3489 USD), respectively for HIV/AIDS patients. The average length of hospital stay was 10.0 ± 5.5 days for HIV patients and 21.7 ± 12.4 days for AIDS patients. For HIV patients, laboratory test fees constituted 37.46% of total expenses; while drug fees accounted for the largest proportion for AIDS patients. Path analysis indicated that the length of hospital stay was the most important factor affecting total expenses (total path coefficient = 0.563 for HIV patients and 0.649 for AIDS patients). Total expenses for HIV-infected females was higher than that of males (total path coefficient = 0.217), and the more complications led to higher expenses for AIDS patients. Conclusions: Though antiretroviral therapy (ART) is provided for free in China, associated medical care, particularly hospitalizations and fees, continue to drive up the medical costs of patients living with HIV and AIDS. Understanding the factors influencing these costs are crucial for determining policies and strategies that can reduce the economic burden of HIV/AIDS patients in China. Keywords: AIDS, HIV, Hospitalization expense, Path analysis
Background Human immunodeficiency virus (HIV) and associated acquired immunodeficiency syndrome (AIDS) are global public health threats, due to their impact on the health and economic well-being of countries. Globally, more than 36 million people were living with HIV in 2017 and 1.8 million became newly infected with the disease in the same year [1]. In China, which is home to more than 1 * Correspondence: [email protected]; [email protected] † Xun Zhuang and Yujia Chen contributed equally to this work. 4 Affiliated Infectious Disease Hospital of Nantong University, Nantong, Jiangsu 226000, People’s Republic of China Full list of author information is available at the end of the article
billion people, the HIV epidemic continues to thrive. According to the National AIDS Epidemic Report of China, there were 758,610 HIV-infected cases in 2017 [2], more than double the number of cases (379,348) reported in 2010 [3]. More so, the disease was responsible for 26,787 deaths in th
Data Loading...
